JP2009521707A5 - - Google Patents

Download PDF

Info

Publication number
JP2009521707A5
JP2009521707A5 JP2008548837A JP2008548837A JP2009521707A5 JP 2009521707 A5 JP2009521707 A5 JP 2009521707A5 JP 2008548837 A JP2008548837 A JP 2008548837A JP 2008548837 A JP2008548837 A JP 2008548837A JP 2009521707 A5 JP2009521707 A5 JP 2009521707A5
Authority
JP
Japan
Prior art keywords
seq
sequence number
infected
detection
probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008548837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009521707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/062632 external-priority patent/WO2007120362A2/en
Publication of JP2009521707A publication Critical patent/JP2009521707A/ja
Publication of JP2009521707A5 publication Critical patent/JP2009521707A5/ja
Pending legal-status Critical Current

Links

JP2008548837A 2005-12-27 2006-12-27 疾患のバイオマーカーとしての脂肪生成アデノウイルス Pending JP2009521707A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75340205P 2005-12-27 2005-12-27
PCT/US2006/062632 WO2007120362A2 (en) 2005-12-27 2006-12-27 Adipogenic adenoviruses as a biomarker for disease

Publications (2)

Publication Number Publication Date
JP2009521707A JP2009521707A (ja) 2009-06-04
JP2009521707A5 true JP2009521707A5 (enExample) 2009-09-10

Family

ID=38610014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008548837A Pending JP2009521707A (ja) 2005-12-27 2006-12-27 疾患のバイオマーカーとしての脂肪生成アデノウイルス

Country Status (11)

Country Link
US (5) US7442511B2 (enExample)
EP (2) EP2390372A1 (enExample)
JP (1) JP2009521707A (enExample)
KR (1) KR20080114683A (enExample)
CN (1) CN101389768B (enExample)
AU (1) AU2006342053A1 (enExample)
BR (1) BRPI0620755A2 (enExample)
CA (1) CA2635269A1 (enExample)
MX (1) MX2008008453A (enExample)
RU (1) RU2008130893A (enExample)
WO (1) WO2007120362A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7507418B2 (en) * 2005-09-09 2009-03-24 Obetech, Llc Adenovirus status as a predictor of body composition change, disease status, and treatment outcomes
AU2006342053A1 (en) * 2005-12-27 2007-10-25 Obetech, Llc Adipogenic adenoviruses as a biomarker for disease
US20120082659A1 (en) * 2007-10-02 2012-04-05 Hartmut Land Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
JP2009156254A (ja) * 2007-12-05 2009-07-16 Ibiden Co Ltd 排気ガス処理体の保持シール部材及び排気ガス処理装置
PL2268618T3 (pl) 2008-03-03 2015-11-30 Novartis Ag Związki i kompozycje jako modulatory aktywności receptorów TLR
WO2010011440A2 (en) * 2008-06-16 2010-01-28 Obetech Llc Diagnosis and treatment of lipogenic adenovirus infection associated with adipose tissue hypertrophy
CN102762226A (zh) 2009-06-10 2012-10-31 诺华有限公司 含苯并萘啶的疫苗
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
ES2443952T3 (es) 2009-09-02 2014-02-21 Novartis Ag Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
WO2011050299A2 (en) * 2009-10-22 2011-04-28 Obetech Llc Adenovirus infection in animals
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
WO2011063131A1 (en) 2009-11-18 2011-05-26 Nohands, Llc Method and system for preventing virus-related obesity and obesity related diseases
US9408907B2 (en) 2009-12-15 2016-08-09 Glaxosmithkline Biologicals Sa Homogenous suspension of immunopotentiating compounds and uses thereof
JP5848748B2 (ja) 2010-03-23 2016-01-27 アイアールエム・リミテッド・ライアビリティ・カンパニーIrm,Llc 感染症、炎症、呼吸器疾患などの処置に使用するtlr2アゴニストとしての化合物(システインベースのリポペプチド)および組成物
WO2011119915A2 (en) * 2010-03-25 2011-09-29 Obetech Llc Method for detecting lipogenic adenovirus
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
CA2803787C (en) * 2010-07-08 2018-12-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease
US20130178517A1 (en) * 2010-07-09 2013-07-11 Richard L. Atkinson Methods And Compositions For Treatment Of Lipogenic Virus Related Conditions
EP2651439B1 (en) 2010-12-17 2018-09-19 Globeimmune, Inc. Compositions and methods for the treatment or prevention of human adenovirus-36 infection
TR201807340T4 (tr) 2013-02-01 2018-06-21 Glaxosmithkline Biologicals Sa Çan benzeri reseptör agonistleri içeren immünolojik kompozisyonların intradermal yoldan verilmesi.
CA2966754A1 (en) 2014-11-05 2016-05-12 The United States Of America As Represented By The Secretary Of The Navy Synthetic antigen constructs against campylobacter jejuni
IL276608B2 (en) 2018-02-12 2024-04-01 Inimmune Corp Toll-like receptor ligands
US20230333111A1 (en) * 2018-10-05 2023-10-19 Minomic International Ltd. Biomarker combinations for determining aggressive prostate cancer
JP2023547676A (ja) 2020-11-04 2023-11-13 エリゴ・バイオサイエンス DNAペイロードをアクネ菌集団へとin situ送達するためのファージ由来粒子

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386800T1 (de) * 1993-03-17 2008-03-15 Us Gov Health & Human Serv Immunogene chimäre umfassend nucleinsäuresequenzen, die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
AU6884298A (en) * 1997-04-04 1998-10-30 Obetech, Llc Viral obesity methods and compositions
JP2000072800A (ja) * 1998-08-26 2000-03-07 Toagosei Co Ltd 抗アデノウイルス37型モノクローナル抗体及びその用途
EP1954131B1 (en) * 2005-11-30 2014-04-02 Board of Supervisors of Louisiana State University and Agricultural and Mechanical College Adenovirus 36 e4 orf 1 gene and protein and their uses
AU2006342053A1 (en) * 2005-12-27 2007-10-25 Obetech, Llc Adipogenic adenoviruses as a biomarker for disease

Similar Documents

Publication Publication Date Title
JP2009521707A5 (enExample)
WO2009061783A3 (en) Dna microarray having hairpin probes tethered to nanostructured metal surface
JP2008532485A5 (enExample)
JP2010029220A5 (enExample)
JP2017516083A (ja) 標的の増幅およびマイクロアレイ検出を集積したマイクロ流体装置
KR20210104835A (ko) 분자 진단을 위한 장치 및 방법
EP2021516A4 (en) NUCLEIC ACID PRIMERS AND PROBES FOR THE DETECTION OF INFLUENZA VIRUSES OF PEOPLE AND BIRDS
JP2007534308A5 (enExample)
DE60020124D1 (de) Verlängerung einer pna-dna chimäre an ihrem 3' ende mittels einer polymerase
JP2015156872A5 (enExample)
Sun et al. A lab-on-a-chip device for rapid identification of avian influenza viral RNA by solid-phase PCR
JP2014513557A5 (enExample)
ATE285479T1 (de) Template abhängige ligierung mit pna-dna chimerischen sonden
WO2007041342A3 (en) Labeled nucleotide analogs and uses therefor
JP2017519774A5 (enExample)
ATE516371T1 (de) Oligonukleotide und deren verwendungen
Teng et al. Specific detection of reverse transcription-loop-mediated isothermal amplification amplicons for Taura syndrome virus by colorimetric dot–blot hybridization
RU2019137083A (ru) Линкеры в виде короткой боковой ручки для нуклеотидов в областях применения секвенирования
JP2005530695A5 (enExample)
JP2009518001A5 (enExample)
WO2019073049A1 (en) ISOTHERMIC AMPLIFICATION IN SOLID PHASE
JP2005505289A5 (enExample)
RU2015143410A (ru) Праймер и способ мультиплексного тестирования с помощью суспензионных микрочипов патогенов, передающихся клещами
JP2014083052A5 (enExample)
JP2011072222A (ja) 標的核酸の検出方法